Scientific, transparent and applicable rankings of Chinese pathological guidelines and consensus published in the medical journals in 2022
10.3760/cma.j.cn112151-20231105-00333
- VernacularTitle:2022年医学期刊发表的中国病理学指南和共识科学性、透明性和适用性评级结果分析
- Author:
Xiaohua SHI
1
;
Shixian WANG
;
Zhe WANG
;
Jian WANG
;
Zhihong ZHANG
;
Yueping LIU
;
Hongying ZHANG
;
Hongwen GAO
;
Xiaoyan ZHOU
;
Qiu RAO
;
Li LIANG
;
Xiaohong YAO
;
Dongge LIU
;
Zhiyong LIANG
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院病理科，北京 100730
- Keywords:
Guideline;
Quality control;
Pathology;
Consensus
- From:
Chinese Journal of Pathology
2024;53(6):528-534
- CountryChina
- Language:Chinese
-
Abstract:
The STAR tool was used to evaluate and analyze the science, transparency, and applicability of Chinese pathology guidelines and consensus published in medical journals in 2022. There were a total of 18 pathology guidelines and consensuses published in 2022, including 1 guideline and 17 consensuses. The results showed that the guideline score was 21.83 points, lower than the overall guideline average (43.4 points). Consensus ratings scored an average of 27.87 points, on par with the overall consensus level (28.3 points). Areas that scored above the overall level were "conflict of interest" and "working groups", while areas that scored below the overall level were "proposals", "funding", "evidence", "consensus approaches" and "accessibility". To sum up, the formulation of pathology guidelines and consensuses in 2022 is not standardized, and the evidence retrieval process, evidence evaluation methods and grading criteria for recommendations on clinical issues are not provided in the formulation process; the process and method for reaching consensus are not provided, the plan is lacking, and registration is not carried out. It is therefore suggested that guidelines/consensus makers in the field of pathology should attach importance to evidence-based medical evidence, strictly follow guideline formulation methods and processes, further improve the scientific, applicable and transparent guidelines/consensuses in the field, and better provide support for clinicians and patients.
